SEC Filing Details

SEC Filing Details

Document Details

Form
NT 10-Q
Filing Date
Aug 16, 2022
Document Date
Jun 30, 2022
Form Description
Notification that form type 10-Q will be submitted late
Filing Group
Quarterly Filings
Company
ReShape Lifesciences
Issuer
RESHAPE LIFESCIENCES INC.
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE